CD8A and neoplasm: In many preclinical tumour models, ExoASO‐STAT6 treatment resulted in an effective conversation TAMs to a pro‐inflammatory M1 phenotype, accompanied by the generation of a CD8 T cell‐mediated adaptive immune response.